OrthoPediatrics (NASDAQ:KIDS - Get Free Report) had its price target lowered by research analysts at Truist Financial from $28.00 to $25.00 in a research note issued on Wednesday,Benzinga reports. The firm presently has a "hold" rating on the stock. Truist Financial's target price would indicate a potential upside of 8.98% from the company's previous close.
Several other equities analysts also recently commented on KIDS. JMP Securities reiterated a "market outperform" rating and set a $50.00 price target on shares of OrthoPediatrics in a report on Friday, September 13th. Needham & Company LLC reaffirmed a "buy" rating and issued a $42.00 price objective on shares of OrthoPediatrics in a research report on Friday, November 8th.
Check Out Our Latest Research Report on KIDS
NASDAQ KIDS traded up $0.48 on Wednesday, hitting $22.94. 34,337 shares of the stock were exchanged, compared to its average volume of 173,005. The company has a debt-to-equity ratio of 0.19, a quick ratio of 3.68 and a current ratio of 7.17. OrthoPediatrics has a 52-week low of $21.02 and a 52-week high of $36.23. The firm has a market capitalization of $555.52 million, a P/E ratio of -18.65 and a beta of 1.14. The stock has a fifty day moving average price of $25.42 and a two-hundred day moving average price of $28.37.
Several institutional investors and hedge funds have recently made changes to their positions in KIDS. Quarry LP bought a new position in OrthoPediatrics during the 3rd quarter worth about $25,000. International Assets Investment Management LLC lifted its position in shares of OrthoPediatrics by 2,610.8% in the 3rd quarter. International Assets Investment Management LLC now owns 1,003 shares of the company's stock worth $27,000 after purchasing an additional 966 shares during the period. Quest Partners LLC bought a new position in shares of OrthoPediatrics during the second quarter valued at approximately $34,000. BNP Paribas Financial Markets increased its holdings in OrthoPediatrics by 125.1% during the third quarter. BNP Paribas Financial Markets now owns 3,471 shares of the company's stock valued at $94,000 after buying an additional 1,929 shares during the period. Finally, SG Americas Securities LLC bought a new position in OrthoPediatrics in the second quarter worth approximately $110,000. 69.05% of the stock is currently owned by institutional investors.
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider OrthoPediatrics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and OrthoPediatrics wasn't on the list.
While OrthoPediatrics currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.